Publications by authors named "Edward Rubenstein"

Claim this Profile
A
Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple Sclerosis.
Raymond A Sobel, Megan Albertelli, Julian R Hinojoza, Mary Jane Eaton, Kevin V Grimes, Edward Rubenstein

J Neuropathol Exp Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome.
Alexander A Morgan, Edward Rubenstein

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial.
Ralph Boccia, Steven Grunberg, Edwin Franco-Gonzales, Edward Rubenstein, Daniel Voisin

Support Care Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.
Camilo Rojas, Ajit G Thomas, Jesse Alt, Marigo Stathis, Jie Zhang, Edward B Rubenstein

Eur J Pharmacol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azetidine-2-carboxylic acid in the food chain.
Edward Rubenstein, Theresa McLaughlin, Richard C Winant, Agustin Sanchez, Michael Eckart

Phytochemistry· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misincorporation of the proline analog azetidine-2-carboxylic acid in the pathogenesis of multiple sclerosis: a hypothesis.
Edward Rubenstein

J Neuropathol Exp Neurol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Camilo Rojas, Marigo Stathis, Ajit G Thomas, Ed B Massuda, Jesse Alt, Edward Rubenstein

Anesth Analg· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.
Edward B Rubenstein, Barbara S Slusher, Camilo Rojas, Rudolph M Navari

Cancer J· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azetidine-2-carboxylic acid in garden beets (Beta vulgaris).
Edward Rubenstein, Haihong Zhou, Karolina M Krasinska, Allis Chien, Christopher H Becker

Phytochemistry· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.
Charlotte C Sun, Diane C Bodurka, Candice B Weaver, Rafia Rasu, Judith K Wolf, Edward B Rubenstein

Support Care Cancer· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of prophylactic quinolones in reducing febrile neutropenia in patients undergoing myelosuppressive chemotherapy.
G Kesava Reddy, Edward B Rubenstein

Support Cancer Ther· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
Stephen T Sonis, Linda S Elting, Dorothy Keefe, Douglas E Peterson, Mark Schubert, Edward B Rubenstein

Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
Edward B Rubenstein, Douglas E Peterson, Mark Schubert, Dorothy Keefe, Deborah McGuire

Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
Steven M Grunberg, Robert R Deuson, Panagiotis Mavros, Olga Geling, Mogens Hansen, Edward B Rubenstein

Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Edward B Rubenstein

Clin Adv Hematol Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based guidelines for managing mucositis.
Deborah B McGuire, Edward B Rubenstein, Douglas E Peterson

Semin Oncol Nurs· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
Linda S Elting, Catherine Cooksley, Mark Chambers, Scott B Cantor, Ellen Manzullo, Edward B Rubenstein

Cancer· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis.
Gerald D Silverberg, Martha Mayo, Thomas Saul, Edward Rubenstein, Dawn McGuire

Lancet Neurol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring chemotherapy-induced nausea and emesis.
Charles G Martin, Edward B Rubenstein, Linda S Elting, Young Jun Kim, David Osoba

Cancer· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy.
Scott B Cantor, Linda S Elting, David V Hudson, Edward B Rubenstein

Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
Ronald Feld, Marianne Paesmans, Alison G Freifeld, Jean Klastersky, Philip A Pizzo, Edward Rubenstein

Clin Infect Dis· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus.
Gerald D Silverberg, Stephen Huhn, Richard A Jaffe, Steven D Chang, Thomas Saul, Edward Rubenstein

J Neurosurg· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?
Charlotte C Sun, Diane C Bodurka, Michele L Donato, Edward B Rubenstein, Candice L Borden

Gynecol Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
Linda S Elting, Charles G Martin, Danna J Kurtin, Scott B Cantor, Edward B Rubenstein

Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis